Title of Collaborative Activity: |
Establishment of representative examination and dose repository for patients undergoing interventional fluoroscopic procedures |
Description of Collaborative Activity: |
NCI and FDA investigators are collaborating to establish representative examination and organ doses for fluoroscopically-guided interventional procedures by collecting anonymized patient data from multiple US clinical institutions. |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
2021 |
NIH Participating Institutes/Centers/Office of the Director: |
|
HHS Agency Collaborators on this Activity: |
FDA |
